Glomerular filtration drug injury:in vitro evaluation of functional and morphological podocyte perturbations by Delézay, Olivier et al.
                          Delézay, O., He, Z., Hodin, S., Saleem, M. A., Mismetti, P., Perek, N., &
Delavenne, X. (2017). Glomerular filtration drug injury: in vitro evaluation
of functional and morphological podocyte perturbations. Experimental Cell




Link to published version (if available):
10.1016/j.yexcr.2017.10.031
Link to publication record in Explore Bristol Research
PDF-document
This is the accepted author manuscript (AAM). The final published version (version of record) is available online
via Elsevier at https://doi.org/10.1016/j.yexcr.2017.10.031 . Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
Contents lists available at ScienceDirect
Experimental Cell Research
journal homepage: www.elsevier.com/locate/yexcr
Glomerular ﬁltration drug injury: In vitro evaluation of functional and
morphological podocyte perturbations
Olivier Delézaya,b,⁎, Zhiguo Heb,c, Sophie Hodina,b, Moin A. Saleemd, Patrick Mismettie,
Nathalie Pereka,b, Xavier Delavennea,b,f
a INSERM, U1059, Dysfonction Vasculaire et Hémostase, Saint-Etienne, France
b Université de Lyon, Saint-Etienne F-42023, France
c EA 2521, Biologie, Ingénierie et Imagerie de la Greﬀe de Cornée (BIIGC), Saint-Etienne, France
d University of Bristol, Bristol Royal Hospital for Children, Bristol, UK
e Unité de Recherche Clinique Innovation et Pharmacologie, CHU de Saint-Etienne, F-42055 Saint Etienne, France
f Laboratoire de Pharmacologie Toxicologie, CHU Saint-Etienne, F-42055 Saint-Etienne, France




In vitro functional toxicity
Permeability
A B S T R A C T
The kidney is an organ that plays a major role in the excretion of numerous compounds such as drugs and
chemicals. However, a great number of pharmacological molecules are nephrotoxic, aﬀecting the eﬃciency of
the treatment and increasing morbidity or mortality. Focusing on glomerular ﬁltration, we propose in this study
a simple and reproducible in vitro human model that is able to bring to light a functional podocyte injury,
correlated with morphologic/phenotypic changes after drug exposure. This model was used for the evaluation of
paracellular permeability of FITC-dextran molecules as well as FITC-BSA after diﬀerent treatments. Puromycin
aminonucleoside and adriamycin, compounds known to induce proteinuria in vivo and that serve here as po-
sitive nephrotoxic drug controls, were able to induce an important increase in ﬂuorescent probe passage through
the cell monolayer. Diﬀerent molecules were then evaluated for their potential eﬀect on podocyte ﬁltration. Our
results demonstrated that a drug eﬀect could be time dependent, stable or scalable and relatively speciﬁc.
Immunoﬂuorescence studies indicated that these functional perturbations were due to cytoskeletal perturba-
tions, monolayer disassembly or could be correlated with a decrease in nephrin expression and/or ZO-1 re-
location. Taken together, our results demonstrated that this in vitro human model represents an interesting tool
for the screening of the renal toxicity of drugs.
1. Introduction
The kidney represents an important target for drug-induced toxicity
since it is responsible for the excretion of numerous xenobiotics and is
continuously exposed to drugs. The ﬁltering unit of the kidney, the
nephron, contains capillaries whose walls function as a ﬁltration bar-
rier. In addition to the glomerular endothelial cells, the ﬁltration pro-
cess implies specialised cells, the podocytes that cover the capillary.
The structural organisation of the podocyte that displays an inter-
digitating structure (foot process) assures a selective ﬁltration of mo-
lecules depending on their size [1]. Considering that the cut-oﬀ is
around 70 kDa, the ﬁnding of albumin in urine is the ﬁrst symptom of
glomerular ﬁltration dysfunction that could be observed in numerous
pathologies [2]. Disorganisation of the podocyte architecture using
nephrotoxic drugs, such as puromycin aminonucleoside (PAN) or
adriamycin (ADR), results in an increase of protein barrier crossing,
conﬁrming the involvement of this cell as a major actor of glomerular
ﬁltration [3,4]. There is a need of simple relevant models to evaluate
the eﬀects of pharmacological drugs on glomerular ﬁltration, to screen
new compounds and to elucidate cellular events involved in functional
perturbations. Numerous rodent models [5,6] have been developed to
study kidney physiology and functionality, but recently research is fo-
cusing on the podocyte considering that this cell is the “weak link” in
the ﬁltration process [7]. In vitro approaches have been studied using
rodent podocytes, but the establishment of a human diﬀerentiation
inducible cell line by M. Saleem oﬀers new perspectives for the study of
the human podocyte [8]. This cell line has been already used for fun-
damental research [9] as well as for the study of cellular events in-
volved in kidney pathologies [10].
Considering that such a model could be used for the screening of
numerous compounds, we chose a simple, standardisable approach
focusing on the podocyte to evaluate the eﬀects of pharmacological
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compounds on glomerular ﬁltration. The goal of our study was to set up
an in vitro human podocyte model in order to be able to predict the
deleterious eﬀect of drugs on glomerular ﬁltration. Selective glomerular
ﬁltration was determined by measuring the apparent permeability of
70 kDa dextran molecules or BSA, before and after drug exposure. The
analysis of morphological modiﬁcations was done to correlate func-
tional perturbations to phenotypic/morphological changes.
2. Materials and methods
2.1. Cell culture
Except when speciﬁed, all the reagents were purchased from Sigma-
Aldrich (Saint-Quentin Fallavier, France). Podocytes were routinely
cultured in RPMI 1640 medium containing 10% foetal bovine serum
(FBS), 1% insulin-transferrin-selenium-A supplement, and 1% peni-
cillin/streptomycin solution. The conﬂuent monolayer was regularly
disrupted by using a trypsin-EDTA solution.
The immortalised human podocytes were routinely cultured at 33 °C
with 95% air and 5% CO2 in 75 cm2 ﬂasks (BD Falcon, Le Pont de Claix,
France). To obtain fully diﬀerentiated podocytes, the cells were swit-
ched to a 37 °C incubator (5% CO2) and cultured in the same medium
for 12–14 d.
For cultures on permeable supports, undiﬀerentiated cells (grown at
33 °C) were seeded at a density of 2.5 × 105 cell per ﬁlter (BD-Falcon
cell culture inserts, 24-well size, 3 µm pore size), cultured 24 h at 33 °C
for cell adhesion and then switched to 37 °C for 12–14 d. Medium was
changed twice a week.
Caco-2 cells, approved by the FDA for in vitro transport studies,
were chosen as a positive control for epithelium tightness since these
cells display a signiﬁcant transepithelial electrical resistance (TEER)
when cultured on permeable support. These cells, grown on DMEM
high glucose medium supplemented with FBS (10%) and 1% penicillin/
streptomycin solution, were seeded at a density of 105 cells per ﬁlter
(3 µm pore size BD Falcon inserts, 24-well plate format). These cells
were used when the TEER (measured with an EVOM resistance meter;
World Precision Instrument, Sarasota, USA) reached a value in the
range of 400 Ω cm2.
2.2. Apparent permeability measurements
The evaluation of selective ﬁltration was done with four FITC-dex-
trans possessing diﬀerent molecular weights (4, 20, 70 and 150 kDa).
Apparent permeability was calculated with the following formula:








Where Papp is the apparent permeability, Vr is the volume of medium
solution in the receiving chamber,C0 is the initial concentration of drug
in the basal compartment, S is the area of the monolayer, C2 is the
concentration of drug found in the apical compartment after an in-
cubation of 4 h, and t is the incubation time.
The experiments were performed with undiﬀerentiated cells, dif-
ferentiated podocytes or Caco-2 cells (control of epithelial tightness).
Podocyte ﬁltration functionality was determined in the basal to apical
direction. Cells were ﬁrst incubated for 1 h at 37 °C in serum-free RPMI
medium (SF-RPMI) and then incubated with FITC-dextran or FITC-BSA
at a concentration of 0.5 g L−1 in the basal compartment (1 mL). After
an incubation of 4 h at 37 °C, 100 µL were taken from the apical com-
partment, transferred into a 96-well plate and ﬂuorescence was mea-
sured using a ﬂuorimeter (Exc = 485 nm, Em = 538 nm; Fluoroskan
Ascent, ThermoFisher Scientiﬁc, Dardilly, France). All the assays were
performed in quadruplicates (n = 4).
2.3. Modulation of podocyte transport by drugs
Drug eﬀect on podocyte permeability was evaluated by using FITC-
BSA, the gold standard protein for determination of glomerular ﬁltra-
tion eﬃciency. The two known nephrotoxic drugs PAN and adriamycin
ADR were used as positive controls for podocyte injury. Diﬀerent
compounds including risedronate (Rise), gentamycin (Gent), vanco-
mycin (Vanco), ketoprofen (Keto), heparin were evaluated for their
capacity to modulate podocyte ﬁltration function.
Podocyte ﬁltration was determined in the basal to apical direction
with the same procedure as described above. The epithelial crossing of
FITC-BSA was then performed as described above.
In addition, a high and a low concentration were tested during
several days (3, 7 or 10 d). The apparent permeability of the podocytes
was evaluated at the end of the incubation time. The two concentra-
tions were chosen in agreement with the literature [11–13] and after
preliminary assays were done to evaluate the highest nontoxic dose for
each compound in our podocyte model. Untreated and PAN-treated
cells served as negative and positive control, respectively, for podocyte
dysfunction. Each experiment was done in quadruplicate (n = 4).
2.4. Cytotoxicity studies
Cell toxicity was evaluated by using the lactate dehydrogenase
(LDH) release test that was purchased from Promega Corporation
(Madison, USA). The experiments were performed according to the
manufacturer's instructions.
2.5. Immunoﬂuorescence studies
Immunoﬂuorescence experiments were performed with Phalloidin-
iFluor 555 (Abcam, Cambridge, UK) and 4',6-diamidine-2'-phenylindole
dihydrochloride (DAPI; Life Technologies, Carlsbad, USA) to visualise
cell cytoskeleton and nucleus, respectively. Mouse anti-ZO-1 antibody
(clone 1) and mouse anti-nephrin antibody (clone 174CT2.1.1), used to
visualise cell-cell contact complexes, were purchased from BD
Bioscience (Le Pont de Claix, France) and from Sigma-Aldrich, respec-
tively. Anti-mouse Alexa Fluor 488 conjugated secondary antibodies,
used to detect primary antibodies, were obtained from Life
Technologies.
Diﬀerentiated podocytes grown on glass coverslips were ﬁxed with
paraformaldehyde (3.7% in PBS) and permeabilised with Triton X-100
(0.5%). Then the cells were incubated with primary antibodies directed
against nephrin (1/50) or ZO-1 (1/50) for 1 h at room temperature,
washed and incubated with the anti-mouse Alexa Fluor 488 conjugated
secondary antibodies (1/200) in the presence of Phalloidin-iFluor 555
and DAPI to visualise F-actin and cell nucleus, respectively. The images
were acquired using an epiﬂuorescence inverted microscope (IX81,
Olympus, Tokyo, Japan) equipped with a cell imaging software (Soft
Imaging System GmbH, Munster, Germany).
3. Results
3.1. Setup of the podocyte in vitro model: morphological aspects
Fig. 1 illustrates the cell line cultured at 33 °C (undiﬀerentiated cell,
left panel) or at 37 °C (diﬀerentiated cells, right panel). Un-
diﬀerentiated cells formed a monolayer of relatively small cells with an
intracytoplasmic peripheral pattern of actin staining. In contrast, dif-
ferentiated podocytes appeared as large spreading cells that possess an
important and multidirectional actin staining with small cytoplasmic
extensions between cells resembling the speciﬁc foot process structure
that is observed in vivo.
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3.2. Evaluation of ﬁltration properties of the podocyte model
The functionality of our podocyte cells was evaluated by measuring
the apparent permeability parameter with a range of molecular weight
dextran molecules and BSA, as illustrated in Fig. 2.
Fig. 2A shows that passage of dextran through podocyte cell
monolayer was dependent on the size of the molecules since the ap-
parent permeability of the 4 kDa dextran was 5.3-fold and 25.2-fold
higher than for the 20 kDa and 70 kDa dextrans, respectively. The Papp
for 70 kDa was 4.8-fold higher with undiﬀerentiated cells than the
value obtained with diﬀerentiated cells. Cell diﬀerentiation was asso-
ciated with a decrease in apparent permeability. As expected, Caco-2
cells, the positive control for epithelial tightness, displayed a reduced
Papp.
Fig. 2B conﬁrms that BSA apparent permeability was also dependent
on podocyte cell diﬀerentiation. The apparent permeability of BSA with
undiﬀerentiated cells was 10-fold higher than the apparent perme-
ability obtained for diﬀerentiated cells (3.7.10−06± 1.1.10−06 cm s−1
vs. 2.3.10−07± 1.1.10−08 cm s−1, respectively). Interestingly, the ap-
parent permeability of BSA obtained with Caco-2 cells,
(3.10−06± 5.9.10−07 cm s−1) was higher than the value obtained for
diﬀerentiated podocytes.
3.3. Impact of nephrotoxic drugs on selective ﬁltration
As expected, the treatment of podocytes for 24 h with PAN in-
creased the epithelial crossing of the FITC-labelled molecule by 3.8
times and by 10-fold for 10 and 50 mg L−1, respectively. The same
results were obtained with ADR with an increase in Papp of 13-fold with
the highest ADR concentration (150 µg L −1). The study of the eﬀect of
these nephrotoxic drugs by using FITC-BSA instead of FITC-dextran
displayed similar results (Fig. 3B).
3.4. Evaluation of pharmacological drugs on podocyte selective ﬁltration
Rise (a bisphosphonate), Gent and Vanco (two antibiotics), Keto (a
nonsteroidal anti-inﬂammatory molecule) and heparin were evaluated
in our model to predict their potential podocyte injury. The con-
centrations were chosen in agreement with the literature and with
preliminary assays which were done. One exposure for 24 h did not
show any signiﬁcant change on BSA apparent permeability
(Supplemental Fig. S1), suggesting that the potential deleterious eﬀect
of these drugs on podocyte ﬁltration needs a longer treatment time.
Podocyte ﬁltration was then evaluated after 3, 7 or 10 days with a high
(Fig. 4A) or a low (Fig. 4B) dose of the considered compound.
The highest concentrations of Gent and Rise were able to increase
the apparent permeability of BSA (Fig. 4A), in contrast to the results
obtained with low doses that were unable to modulate the permeability
of BSA across the podocyte barrier (Fig. 4B). In the case of Gent, the
eﬀect was time dependent, reaching a value of 49-fold the value ob-
tained with control cells after 3 exposures (10 d of treatment). The ef-
fect of Rise on podocyte ﬁltration was earlier and relatively stable
during time. In contrast to these drugs, Vanco or Keto did not alter
podocyte ﬁltration, suggesting a relative speciﬁcity of the eﬀects ob-
tained with Gent and Rise on the epithelial crossing of albumin. He-
parin (200.103 U L−1) was able to signiﬁcantly enhance BSA perme-
ability after 3 d. This eﬀect increased during time (Fig. 4C). LDH release
measurements indicated that none of the treatments were toxic since
any diﬀerence in LDH release could be noticed between treated or
untreated cells in the supernatants (data not shown).
3.5. Evaluation of morphological changes induced by drugs
The expression and distribution of F-actin, ZO-1 and nephrin were
analysed on diﬀerentiated podocytes treated for 3 d with the diﬀerent
drugs. The eﬀect of the two nephrotoxic drugs (PAN and ADR) are
shown in Fig. 5. The treatment of the cells with PAN was associated
with a redistribution of the F-actin network that was located near the
cytoplasmic membrane instead of the homogeneous distribution ob-
served for untreated cells. ADR treatment was also associated with such
a phenomenon as well as in cell-cell contact disruption with the ap-
pearance of isolated rounded cells. ADR treatment induced a decrease
in cell size, with the cells resembling undiﬀerentiated rounded cells.
The labelling of ZO-1 on untreated cells was continuous along cell
borders with some interdigitating signals at the cell-cell contacts. This
Fig. 1. Morphological aspect of undiﬀerentiated (left panel) and diﬀerentiated podocytes
(right panel). Cells grown on glass coverslips were ﬁxed, permeabilised and incubated
with Phalloidin-iFluor 555 and DAPI before being observed with a ﬂuorescent micro-
scope. In addition to an important diﬀerence in cell size, F-actin staining (in red) revealed
diﬀerent patterns of localisation.
Fig. 2. Evaluation of FITC-dextran or FITC-BSA apparent permeability on undiﬀerentiated and diﬀerentiated podocytes or on Caco-2 cells. Cells grown on permeable supports were tested
for their permeability properties by using FITC-dextran possessing diﬀerent molecular weights (A) or FITC-BSA (B) on undiﬀerentiated cells (white bars) diﬀerentiated podocytes
(blackbars) or Caco-2 cells (hatched bars). Results are expressed as the mean± SD of the apparent permeability (cm s−1) of four independent experiments.
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pattern was identical on PAN-treated cells in contrast to the signal
obtained after ADR treatment that resulted in a decrease in inter-
digitating structures associated with a redistribution of the protein on
cell plasma membrane as patches. The expression of the nephrin protein
was strongly decreased, resulting in a loss of the dot signal or in the dot
and intracellular signals for PAN or ADR treated cells, respectively.
Similar immunoﬂuorescence studies (Fig. 6) were conducted on
podocytes treated for 7 d with Gent (400 mg L−1), Rise (30 mg L−1),
and heparin (200.103 U L−1). Gent treatment was associated with an
important relocation of actin that was found near the cytoplasmic
membrane and resembled the pattern observed with PAN-treated cells.
Moreover, important spaces between cells appeared, suggesting cell-cell
contact disruption. However, the expression of ZO-1 appeared to be
unaﬀected by Gent in contrast to nephrin expression that was clearly
reduced. The bisphosphonate Rise also provoked monolayer dissocia-
tion with the appearance of small rounded isolated cells. The loss of
Fig. 3. Evaluation of permeability changes induced by drugs. Diﬀerentiated podocytes grown on permeable support were incubated for 24 h with puromycin aminonucleoside (PAN) or
adriamycin (ADR) for the indicated concentrations before being evaluated for dextran (A) or BSA (B) permeability. The values are shown as the mean± SD of four independent assays.
Fig. 4. Evaluation of drug eﬀect on BSA permeability. Podocytes were grown on permeable support and then incubated with the high (A) or low (B) concentrations of diﬀerent drugs for 3
(white bars), 7 (hatched bars) or 10 (black bars) days before being evaluated for BSA permeability. Untreated cells served as negative control and puromycin aminonucleoside was used as
a positive control for monolayer ﬁltration perturbation. The results are expressed as the mean± SD of four independent experiments.
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cell-cell contact was also observed with the ZO-1 labelling, which was
visualised as patches between separating cells instead of linear or in-
terdigitating patterns observed between cells in close contact. This
treatment was also associated with a dramatic decrease in nephrin ex-
pression, since very few cells displayed the speciﬁc dot pattern label-
ling. Similarly, heparin was able to dissociate the cells in some areas
with the appearance of rounded cells. However, in residual conﬂuent
cell areas that were similar to those observed for untreated cells, the
ZO-1 pattern appeared unchanged as compared to control cells. This
was also the case for the expression of nephrin that was unchanged in
conﬂuent cell areas.
4. Discussion
Drug-induced nephrotoxicity is a major problem in clinical human
therapy since the use of nephrotoxic drugs is often unavoidable. Thus,
the prediction of drug nephrotoxicity appears of particular relevance in
order to avoid kidney injury and/or perturbation of pharmacokinetic
drug properties that are closely related to kidney excretion [14].
Moreover, the possibility to optimise drug design by using a functional
screening in vitro model represents an interesting tool for the char-
acterization of drug toxicity and/or for the development of news drugs.
Numerous in vivo or in vitro models have been developed to explore the
glomerular ﬁltration [15]. However, these models are not always re-
presentative of human physiology (interspecies variations of in vivo
models) or could not be easily used for the screening of drugs because of
their complexity or costs (ex vivo approach).
In this study, we have used a simple standardised human in vitro
model in order to measure the eﬀect of diﬀerent drugs on podocyte
glomerular ﬁltration. The setup of the model was based on the culture
of human podocytes [8] on permeable support allowing the measure-
ment of dextran or BSA epithelial crossing. Immunoﬂuorescence ex-
periments were done to analyse the morphologic/phenotypic changes
induced by diﬀerent treatments. To our knowledge, this is the ﬁrst time
that such approach is done for the evaluation of the nephrotoxicity of
drugs with a focus on the glomerular ﬁltration. In the great majority of
Fig. 5. Eﬀects of puromycine aminonucleoside (PAN) and adriamycin (ADR) on podocyte cytoskeleton, ZO-1 and nephrin expressions. Diﬀerentiated cells grown on glass coverslips were
treated or not (NT) with PAN (10 mg L−1) or ADR (100 µg L−1) for 3 d before being ﬁxed and permeabilised. Phalloidin-iFluor 555 was used to visualise the F-actin cytoskeleton
component (in red). DAPI was used for nucleus labelling (in blue). Cells were also incubated with antibodies directed against ZO-1 or nephrin that were revealed (in green) by using
AF488 conjugated goat anti-mouse IgG antibodies. Omission of the primary antibody served as negative control.
O. Delézay et al. Experimental Cell Research xxx (xxxx) xxx–xxx
5
cases, in vitro nephrotoxicity assays are performed by using proximal
tubular cells without considering the podocyte that represents, never-
theless, a potential target for drugs. Our model appears to be closed to
the functional state of normal human renal cells displaying a selective
ﬁltration that could be modulated by nephrotoxic drugs (PAN and ADR)
known to induce proteinuria in vivo [16,17]. In addition, the analysis of
F-actin distribution and nephrin or ZO-1 expression indicates a good
correlation between functional and morphologic events due to treat-
ments with these two drugs. In the absence of electron microscopic
experiments, we cannot formally demonstrate that diﬀerentiated po-
docytes form slit diaphragms in our hands but the fact that podocyte
monolayer displays a selective ﬁltration and that this process could be
perturbed by PAN and ADR, known to provoke foot process eﬀacement,
argue in favour to this point. The use of the phenotypic analysis com-
bined with a functional test that reveals drug injury represents an in-
novative tool for the evaluation of drug injury.
Based on these considerations, we used this approach to test a panel
of diﬀerent molecules. We selected two antibiotics (Gent and Vanco), a
bisphosphonate (Rise) a nonsteroidal anti-inﬂammatory drug (Keto)
and heparin. These compounds were chosen since they could exert a
nephrotoxicity but little is known about their actions on the glomerular
ﬁltration.
Gent, an aminoglycoside, could act on the proximal tubular part of
the kidney, inducing an apoptosis [18] or a necrosis [19] of the epi-
thelial cells. In the glomeruli, Gent could also promote mesengial
contraction [20], resulting in a decrease in glomerular ﬁltration. Vanco,
that belongs to the class of the glycopeptides, could provoke interstitial
nephritis [21]. In the two cases, the eﬀect of these molecules on po-
docytes is not documented. Non-steroidal anti-inﬂammatory drugs
could also exert a nephrotoxicity modulating the vasoconstriction of
aﬀerent blood vessels [22,23]. Heparin has been described as a com-
pound able to modulate the expression of speciﬁc proteins expressed by
podocyte suggesting a potential eﬀect on the glomerular ﬁltration [24].
Bisphosphonates, used to reduce bone resorption in osteoporosis or in
the cases of osteolytic bone metastases, are known to provoke tubular
necrosis and collapsing focal segmental glomerulosclerosis [25]. They
could act directly on podocytes, leading to a dediﬀerentiation and a
proliferation of the cells [26]. Since the nephrotoxic eﬀects could be
dose and duration dependent, podocytes were continuously exposed to
a low or a high concentration and tested for BSA transport after 3,7 or
10 days.
Our results clearly demonstrated that treatment of podocytes with
Rise, Gent and heparin was able to modulate the permeability of BSA
across the podocyte monolayer. The perturbation of podocyte ﬁltration
by drugs was only observed with the high concentrations, indicating
that the ﬁltration property was relatively resistant to long time ex-
posure with low drug concentrations. The monolayer disruption, the
perturbation of actin cytoskeleton and/or the decrease in nephrin ex-
pression could explain, at least in part, this result. It should be noted
that whatever the treatment, no cellular toxicity could be observed by
Fig. 6. Visualisation of phenotypic and morphologic changes induced by drug treatments. Podocytes were cultured during 7 d with gentamycin (400 mg L−1), risedronate (30 mg L−1) or
heparin (200.103 U L−1) before being ﬁxed and permeabilised. Cells were then incubated with DAPI (blue) and phalloidin (red) to visualise cell nucleus or F-actin cytoskeleton
components, respectively. Cells were also incubated with antibodies directed against ZO-1 or nephrin that were revealed (in green) with AF488 conjugated goat anti-mouse IgG
antibodies. Omission of the primary antibody served as negative control.
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LDH release measurements. An interesting ﬁnding was that these eﬀects
were time dependent, since some drugs were able to alter quickly the
podocyte function (Rise, heparin), while others exerted a deleterious
eﬀect after a longer time exposure (Gent). Moreover, the functional
injury appeared relatively stable during time for Rise or, in contrast,
was scalable for Gent and heparin. Gent is known as a nephrotoxic drug
that acts on proximal tubular cells. Interestingly, our data demonstrated
that Gent could also alter glomerular ﬁltration through a direct action
on the podocyte. In our experiments, the eﬀect of Gent was greater than
that obtained with PAN after 10 d of treatment, suggesting an im-
portant deleterious action of this antibiotic on glomerular ﬁltration.
This unexpected data suggest that our functional test could highlight
new mechanisms that could explain the nephrotoxicity of drugs. This
eﬀect appeared to be relatively speciﬁc since Vanco, used in the same
conditions, was unable to promote a signiﬁcant increase in BSA per-
meability. This result corroborates previous data that indicated that
Vanco could be responsible for interstitial nephritis [21] rather than a
direct action on podocytes. Similarly, Keto does not modify the ﬁltra-
tion, in agreement with the fact that nonsteroidal anti-inﬂammatory
compounds aﬀect glomerular ﬁltration rate by acting on blood vessels.
These results indicate that our model is selective and, obviously, could
diﬀerentiate drugs according to their cellular targets. The treatment of
podocytes with the bisphosphonate Rise resulted in a rapid and sig-
niﬁcant increase in albumin epithelial crossing. Our immuno-
ﬂuorescence experiments showed monolayer disruption, the appear-
ance of rounded isolated cells resembling undiﬀerentiated podocytes, as
well as a decrease in nephrin expression, which are in agreement with
an eﬀect of Rise on cell diﬀerentiation status. Heparin was also able to
increase the epithelial crossing of BSA, suggesting that it could alter
podocyte ﬁltration function. This result is not in agreement with the
results obtained by Yaoita et al. that demonstrated an increase in ne-
phrin expression after heparin cell treatment, suggesting a potential
beneﬁt of heparin on glomerular ﬁltration [24]. Despite these potential
discordances, our results indicated that heparin is responsible for
monolayer disruption rather than nephrin or ZO-1 down modulation,
since conﬂuent cell monolayer was comparable to that observed for
untreated cells. This point indicates that functional tests are an im-
portant complementarity approach to protein expression studies and
are pertinent to evaluating the drug eﬀect. Other studies have reported
a reduction of proteinuria after heparin treatment in PAN or ADR in-
jured rats [27,28]. These results demonstrated that heparin could re-
store glomerular ﬁltration function after drug injury. Since heparin
could act at numerous levels in the kidney ﬁltration process, it will be
interesting to explore its eﬀects in our cellular in vitro model to better
understand its action on the podocyte. In particular, it will be inter-
esting to evaluate the eﬀect of heparin on podocyte adhesion by the
measurement of integrin expression. Experiments will be performed in
our laboratory to elucidate this point.
We think that our approach, using a simpliﬁed in vitro model, is
suitable for the rapid screening of numerous pharmacological com-
pounds as well as for the evaluation of the potential nephrotoxicity of
new drugs. This point is reinforced by the fact that immunoﬂuorescence
experiments, that display monolayer organisation changes, variations
in cytoskeleton distribution or protein expressions, are correlated with
functional data. To our knowledge, this is the ﬁrst time that the com-
bination of functional and morphological studies is done to evaluate the
nephrotoxicity of pharmacological compounds. However, the glo-
merular ﬁltration is not only the fact of podocyte but is also the result of
the fenestred endothelial cells and the basal membrane. It will be per-
tinent to improve this model with endothelial cells. Nevertheless, since
glomerular ﬁltration deﬁciency often correlates with podocyte injury,
we focused our study on this cell. Our simpliﬁed podocyte model could
be of real interest for the prediction of drug-induced “podocytopathy”
before clinical tests as well as for the optimisation of drug design. It also
could be used for the screening of compounds that could restore po-
docyte ﬁltration properties after podocyte injury.
Appendix A. Supporting information
Supplementary data associated with this article can be found in the
online version at http://dx.doi.org/10.1016/j.yexcr.2017.10.031.
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